| 100034-8 | Provider of automated external defibrillator use |
| 100037-1 | Patient contact disposition EMS unit |
| 100038-9 | Patient evaluation disposition EMS unit |
| 100039-7 | Crew disposition for patient care EMS unit |
| 100040-5 | Patient transport disposition EMS unit |
| 100086-8 | Right cornea Type of Analysis method (specular microscopy) |
| 100155-1 | Left cornea Type of Analysis method (specular microscopy) |
| 100156-9 | SARS-CoV-2 (COVID-19) variant in Specimen (naa with probe detection) |
| 100157-7 | SARS-CoV-2 (COVID-19) lineage in Specimen (sequencing) |
| 100160-1 | Knee replacement (qualitative) |
| 100869-7 | Cryptosporidium gp60 gene in Specimen (molecular genetics method) |
| 100975-2 | Induced abortion method |
| 101003-2 | Monkeypox virus clade in Specimen (sequencing) |
| 101004-0 | Monkeypox virus lineage in Specimen (sequencing) |
| 101394-5 | Sex in Embryo (molecular genetics method) |
| 101807-6 | Malnutrition risk screen results indicator |
| 102080-9 | CAR-T cell product unit (Blood) |
| 102120-3 | Carbapenemase in Isolate (immunoassay) |
| 10216-0 | Surgical operation note fluids Narrative |
| 10224-4 | Hemodynamic method special circumstances |
| 10229-3 | Hemodynamic method Type of |
| 10253-3 | Type of Biliary drain |
| 10254-1 | Type of Peritoneal drain |
| 10255-8 | Type of Subarachnoid drain |
| 10277-2 | Stool collection site |
| 103141-8 | Staphylococcus aureus MLVA complex in Isolate or Specimen (molecular genetics method) |
| 103223-4 | Workout intensity (qualitative) |
| 10331-7 | Rh (Blood) |
| 103601-1 | Staphylococcus aureus MLVA type in Isolate or Specimen (molecular genetics method) |
| 103708-4 | Race during assessment period |
| 103847-0 | Extracorporeal membrane oxygenation ECMO device |
| 10385-3 | Albumin concentration given |
| 10389-5 | Blood product.other |
| 10390-3 | Blood product special preparation |
| 10393-7 | Factor IX given |
| 10395-2 | Factor VIII given |
| 10401-8 | Immune serum globulin given |
| 104064-1 | Medical specialty responsible for patient after ICU discharge |
| 10410-9 | Plasma given |
| 10412-5 | Platelets given |
| 104262-1 | Diagnostic peripheral vascular disease study Heart |
| 104324-9 | Acinetobacter sp identified in Specimen (sequencing) |
| 104326-4 | Adenovirus sp identified in Specimen (sequencing) |
| 104534-3 | Consistency (Urine) |
| 104723-2 | Medication role |
| 104736-4 | Clinician guidance Medication Narrative |
| 104818-0 | Medication parsable directions Medication Narrative |
| 104902-2 | Electronic communication information |
| 104907-1 | Indication Narrative |
| 104916-2 | Language of communication information Person |
| 104929-5 | Family member problem Family member Narrative |
| 104931-1 | Procedure method Narrative |
| 104934-5 | Imaging examination name |
| 104953-5 | Care plan request information |
| 105302-4 | Immune stain PD-L1 scoring method - Tissue |
| 105415-4 | Clinical decision support for ICU discharge |
| 10568-4 | Clarity (Semen) |
| 10573-4 | Ferning in Cervical mucus |
| 106000-3 | First food |
| 106162-1 | Allergy Category |
| 106169-6 | Body landmark orientation |
| 106622-4 | Cesarean status (qualitative) |
| 106648-9 | Alcoholic drink consumed |
| 106789-1 | Where was the pregnancy followed-up |
| 106862-6 | Arachis hypogaea recombinant (rAra h1 and 2 and 3) Ab.IgE and IgD and IgG4 and IgA (qualitative, immunoassay) |
| 107032-5 | Drug class tested in Specimen |
| 107134-9 | Multimedia file name Narrative |
| 107444-2 | Unit of measure in Specimen |
| 107454-1 | Administrative gender |
| 108085-2 | SARS-CoV-2 (COVID-19) lineage in Nasopharynx (sequencing) |
| 108099-3 | Measles virus genotype (Urine) |
| 108100-9 | Measles virus genotype in Throat |
| 108101-7 | Measles virus genotype (Blood) |
| 108102-5 | Measles virus genotype in Specimen |
| 108246-0 | Accommodation type |
| 108247-8 | Living accommodation heating system |
| 108248-6 | Household income |
| 108254-4 | Accommodation occupancy regime |
| 108265-0 | Therapy services during assessment period |
| 108272-6 | Household expenditure |
| 11029-6 | Consistency (Stool) |
| 111474-3 | Associated risk factor Newborn |
| 111528-6 | Residential situation |
| 111529-4 | Where were or have you been staying |
| 111828-0 | Type Endoscopy |
| 111834-8 | Antithrombotic agents |
| 111837-1 | Replacement medicine 1 |
| 111838-9 | Replacement medicine 2 |
| 111852-0 | Purpose of examination Colon Colonoscopy |
| 111860-3 | Insertion route Small bowel Endoscopy |
| 111861-1 | Antispasmodic agents use status Endoscopy |
| 111862-9 | Sedation-analgesia-anesthesia Endoscopy |
| 111863-7 | Type of air-gas Endoscopy |
| 111870-2 | Image-Enhanced endoscopy Gastrointestinal tract upper Endoscopy |
| 111871-0 | Image-Enhanced endoscopy Colon Colonoscopy |
| 111872-8 | Image-Enhanced endoscopy Small bowel Endoscopy |
| 112037-7 | Purpose of examination Gastrointestinal tract upper Endoscopy |
| 112040-1 | Insertion route Gastrointestinal tract upper Endoscopy |
| 112060-9 | Purpose of treatment Gastrointestinal tract upper Endoscopy |
| 112061-7 | Atrophy degree Gastrointestinal tract upper Endoscopy |